| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Monday, July 16, 2012
Stockdiagnostics Upgrades : Weekend Stats
the following posts were posted at Equities Research this weekend.
Monday, July 9, 2012
Amerigroup, 21st Stockdiagnostics Upgrade Acquired in 7 Months
originally published at Equities Research with charts
7/9/2012
Amerigroup Corporation (NYSE: AGP) announced today it will be acquired for $92 a share by WellPoint, Inc (NYSE: WLP). Stockdiagnostics upgraded AGP @ $38.96 on August 9,2010 after the company reported 2nd quarter financials for the period ending June 30,2010. In less than 2 years since the upgrade shares have appreciated 136%.
<click to AGP Stockdiagnostics OPS chart
<click to AGP Stockdiagnostics OPS 5 year chart
<click to AGP Stockdiagnostics FCF chart
<click to AGP Stockdiagnostics FCF 5 year chart
<click to AGP GFNN news story 2
<click to AGP GFNN news story
21 Stockdiagnostics Upgrades Recently Acquired
7/9/2012
Amerigroup Corporation (NYSE: AGP) announced today it will be acquired for $92 a share by WellPoint, Inc (NYSE: WLP). Stockdiagnostics upgraded AGP @ $38.96 on August 9,2010 after the company reported 2nd quarter financials for the period ending June 30,2010. In less than 2 years since the upgrade shares have appreciated 136%.
<click to AGP Stockdiagnostics OPS chart
<click to AGP Stockdiagnostics OPS 5 year chart
<click to AGP Stockdiagnostics FCF chart
<click to AGP Stockdiagnostics FCF 5 year chart
<click to AGP GFNN news story 2
<click to AGP GFNN news story
21 Stockdiagnostics Upgrades Recently Acquired
| company | ticker | Acquirer LOI | date | $ Upgrade | $ Close | Time | % Return | vs.S&P500 |
| Amerigroup Corp. | AGP | WellPoint | 7/9/2012 | $38.96 | $92.00 | 23 mos | 136% | 19.92% |
| Amylin Pharmaceutica | AMLN | Bristol-Myer | 6/29/2012 | $12.51 | $31.00 | 13 mos | 145% | 1.50% |
| Integramed America | INMD | SCP, L.P. | 6/11/2012 | $13.68 | $10.30 | 15 mos | 32% | 0.81% |
| Edgar Online, Inc. | EDGR | R.R.Donnell | 5/23/2011 | $0.76 | $1.08 | 9 mos | 42% | 10.47% |
| Aribe Inc. | ARBA | SAP | 5/22/2011 | $7.34 | $45.00 | 6 yrs | 513% | -6.81% |
| Golfsmith It'l Hold,Inc | GOLF | Golf Town | 5/14/2012 | $4.15 | $6.10 | 14 mos | 47% | 2.15% |
| GTSI Corporation | GTSI | UniCom | 5/14/2012 | $7.71 | $5.00 | 1 yr | 54% | 1.68% |
| Cost Plus, Inc. | CPWM | BBBY | 5/10/2012 | $4.58 | $22.00 | 2 yrs | 380% | 28.64% |
| Easy Link Service Int | ESIC | Open Text | 5/3/2012 | $1.80 | $7.16 | 29 mos | 302% | 26.97% |
| Charming Shoppes | CHRS | Ascena R | 5/2/2012 | $4.18 | $7.35 | 13 mos | 75% | 5.57% |
| Ardea Biosciences Inc | RDEA | AstraZen | 4/24/2012 | $3.35 | $32.00 | 6 yrs | 855% | 6.02% |
| Knology Inc. | KNOL | WOW, Int | 4/18/2012 | $9.91 | $19.75 | 6 yrs | 99% | 6.76% |
| X-Rite, Incorporated | XRIT | Danaher | 4/11/2012 | $1.97 | $5.54 | 3 yrs | 181% | 51.49% |
| Transcend Services | TRCR | Nuance | 3/8/2012 | $14.64 | $29.18 | 5 years | 100% | -9.28% |
| CH Energy Group,Inc | CHG | Fortis | 3/6/2012 | $50.67 | $66.60 | 9 mos | 31% | 4.22% |
| Sera Care Life Science | SRLS | Linden CP | 3/6/2012 | $0.90 | $3.97 | 3 yrs | 342% | 51.98% |
| Taleo Corporation | TLEO | Oracle | 2/10/2012 | $8.00 | $45.00 | 3 yrs | 469% | 54.28% |
| Pep Boys-Many,Moe,J | PBY | Gores | 1/31/2012 | $9.58 | $15.00 | 5 mos | 56% | 12.92% |
| Novellus Systems Inc | NVLS | Lam Resear | 12/15/2011 | $26.00 | $44.00 | 16 mos | 70% | 55.95% |
| Demand Tec, Inc. | DMAN | IBM Corp | 12/9/2012 | $5.45 | $13.20 | 5 mos | 70% | 8.45% |
| Success Factors, Inc. | SFSF | SAP of GMY | 12/4/2011 | $7.75 | $40.00 | 3 yrs | 416% | -4.10% |
Saturday, July 7, 2012
Equities Research Maintains SELL RATING on CMG & UA
My work (Equities Research, Tommy Renna) is mentioned near the two minute mark of this CNBC TV clip.
CMG
After being bullish on Chipotle Mexican Grill (NYSE: CMG) for nearly 6 years and watching the stock soar from $50 to $440, on the morning of April 20,2012 I became bearish. Since my Sell rating ($430.78) that morning shares have declined $47 or -11% vs. the S&P500 index which has decline 1.62% over the same 11 week period.
click to view my sell call mention on CNBC TV 4/20/2012 (approx. 2 minutes into clip)
UA
I issued a Sell rating on Under Armour (NYSE: UA) four weeks ago when shares hit a new all time high @ $105. Since the call, shares of UA have declined $13 or -12.55% vs the S&P500 index which is up 2.19% over the same period.
Earnings Season kicks off this week and I will be busy examining 10Qs & 10Ks looking for companies with weakening fundamentals trading at premiums that I will recommend as short picks.
Companies growing fundamentals that are trading at discounts in the market place will be included in by long picks.
All my research is 100% objective, give it a try and subscribe today.
A newsletter subscription is well worth the time and energy that I will save you from doing the work.
*Remember, I am only looking for value stocks that are growing on the long side and overbought stocks trading at premiums with weakening fundamentals on the sell side.
"Common yardsticks such as dividend yield, the ratio of price to earnings or to book value, and even growth rates have nothing to do with valuation except to the extent they provide clues to the amount and timing of cash flows into and from the business. Indeed, growth can destroy value if it requires cash inputs in the early years of a project or enterprise that exceed the discounted value of the cash that those assets will generate in later years.
Market commentators and investment managers who glibly refer to
Market commentators and investment managers who glibly refer to
growthand
valuestyles as contrasting approaches to investment are displaying their ignorance, not their sophistication. Growth is simply a component--usually a plus, sometimes a minus-- in the value equation."
Labels:
Chipotle,
Earning Season,
Equities Research,
Renna,
Under Armour,
Warren Buffett
Subscribe to:
Posts (Atom)